Zepp Health Corporation (ZEPP)

USD 2.77

(2.97%)

EBITDA Summary of Zepp Health Corporation

Zepp Health Corporation's latest annual EBITDA in 2023 was -134.39 Million CNY , up 62.05% from previous year.
Zepp Health Corporation's latest quarterly EBITDA in 2024 Q2 was -8.79 Million USD , up 39.72% from previous quarter.
Zepp Health Corporation reported an annual EBITDA of -354.08 Million CNY in 2022, down -333.64% from previous year.
Zepp Health Corporation reported an annual EBITDA of 93.94 Million CNY in 2021, up 43.86% from previous year.
Zepp Health Corporation reported a quarterly EBITDA of -8.79 Million USD for 2024 Q2, up 39.72% from previous quarter.
Zepp Health Corporation reported a quarterly EBITDA of N/A for 2023 FY, up 62.05% from previous quarter.

Annual EBITDA Chart of Zepp Health Corporation (2023 - 2015)

Historical Annual EBITDA of Zepp Health Corporation (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	-134.39 Million CNY	62.05%
2022	-354.08 Million CNY	-333.64%
2021	93.94 Million CNY	43.86%
2020	105.34 Million CNY	-82.58%
2019	623.69 Million CNY	69.09%
2018	357.59 Million CNY	99.11%
2017	185.68 Million CNY	1037.98%
2016	15.78 Million CNY	139.62%
2015	-39.82 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	-105.97 Million CNY	-973.33%
2024 Q2	-8.79 Million USD	39.72%
2023 FY	- CNY	62.05%
2023 Q3	14.99 Million CNY	122.3%
2023 Q2	-67.21 Million CNY	54.82%
2023 Q1	-148.76 Million CNY	-121.72%
2023 Q4	12.13 Million CNY	-19.06%
2022 Q1	-149.14 Million CNY	-510.67%
2022 FY	- CNY	-333.64%
2022 Q4	-67.09 Million CNY	-111.5%
2022 Q3	-31.72 Million CNY	70.11%
2022 Q2	-106.12 Million CNY	28.84%
2021 Q1	-41.96 Million CNY	-7614.71%
2021 Q3	67.79 Million CNY	-10.69%
2021 FY	- CNY	43.86%
2021 Q2	75.9 Million CNY	280.87%
2021 Q4	36.31 Million CNY	-46.43%
2020 Q4	-544 Thousand CNY	-100.7%
2020 Q3	77.27 Million CNY	721.13%
2020 Q1	19.2 Million CNY	-91.1%
2020 Q2	9.41 Million CNY	-51.0%
2020 FY	- CNY	-82.58%
2019 Q2	92.1 Million CNY	18.68%
2019 Q4	215.83 Million CNY	-1.5%
2019 Q1	77.6 Million CNY	-36.97%
2019 FY	- CNY	69.09%
2019 Q3	219.11 Million CNY	137.89%
2018 Q1	8.82 Million CNY	-88.2%
2018 Q3	126.62 Million CNY	27.88%
2018 Q4	123.12 Million CNY	-2.77%
2018 FY	- CNY	99.11%
2018 Q2	99.02 Million CNY	1021.95%
2017 Q2	58.17 Million CNY	1172.29%
2017 FY	- CNY	1037.98%
2017 Q4	74.79 Million CNY	43.69%
2017 Q3	52.05 Million CNY	-10.52%
2017 Q1	-5.42 Million CNY	-112.25%
2016 Q4	44.27 Million CNY	0.0%
2016 FY	- CNY	139.62%
2015 FY	- CNY	0.0%

Peer EBITDA Comparison of Zepp Health Corporation

Name	EBITDA	EBITDA Difference
Babcock & Wilcox Enterprises, I	-267 Thousand USD	-50234.457%
Babcock & Wilcox Enterprises, I	-267 Thousand USD	-50234.457%
VIZIO Holding Corp.	32.2 Million USD	517.37%